(Q44303896)

1 December 2017

title

A novel attenuated replication-competent adenovirus for melanoma therapy (English)

1 reference

1 December 2017

1 reference

Peter I

1 reference

1 December 2017

Graf C

1 reference

1 December 2017

Dummer R

1 reference

1 December 2017

Schaffner W

1 reference

1 December 2017

Greber UF

1 reference

1 December 2017

Hemmi S

1 reference

1 December 2017

publication date

1 April 2003

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

530-539

1 reference

1 December 2017

cites work

Cancer statistics, 1998

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Gene therapy for cancer: what have we done and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Viral shedding and biodistribution of G207, a multimutated, conditionally replicating herpes simplex virus type 1, after intracerebral inoculation in aotus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Reovirus therapy of tumors with activated Ras pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Modulation of the specificity and activity of a cellular promoter in an adenoviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Creation of a new transgene cloning site near the right ITR of Ad5 results in reduced enhancer interference with tissue-specific and regulatable promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Melanocyte-specific expression of the human tyrosinase promoter: activation by the microphthalmia gene product and role of the initiator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Characterization of Gene Regulatory Elements for Selective Gene Expression in Human Melanoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Functional analysis of the nucleotide sequence surrounding the cap site for adenovirus type 5 region E1A messenger RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Development and application of adenoviral vectors for gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Manipulation of Adenovirus Vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Augmentation of melanoma-specific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Tyrosinase protein is expressed also in some neural crest derived cells which are not melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Signalling in viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Comparative Analysis of the In Vivo Expression of Tyrosinase, MART-1/Melan-A, and gp100 in Metastatic Melanoma Lesions: Implications for Immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Update on adenovirus and its vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301940

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301940

1 reference

1 December 2017

1 reference